Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)

Abbott Park, Illinois, U.S. All United States companies → — Founded 1888

Healthcare Conglomerate Medical Device / Hardware Wearables / RPM

Cardiology Critical Care Hospital Medicine

Cardiology AI Wearables & Remote Monitoring (RPM)

Public Company — Unknown

Claim this company

Products

Assert-IQ (DM5100)

Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)

Cardiology AI

The Assert-IQ™ Insertable Cardiac Monitor (ICM) is a Bluetooth-enabled device from Abbott that provides continuous, real-time heart monitoring and arrhythmia detection, utilizing AI algorithms to reduce false positives and offer long-term diagnostic evaluation for patients with cardiac conditions.

See all 1 product →

About Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)

Abbott’s Assert-IQ™ Insertable Cardiac Monitor (ICM) is a cutting-edge medical device that integrates advanced AI algorithms to enhance cardiac monitoring and patient management. This Bluetooth-enabled ICM is designed for long-term, reliable heart rhythm monitoring, offering options with battery lives of at least three or six years. The device is subcutaneously inserted in the left pectoral region and continuously checks heart rhythms, transmitting important findings in near real-time to a clinic’s portal, often via the patient’s own mobile phone. The Assert-IQ ICM is indicated for patients experiencing unexplained cardiac-related symptoms such as dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as those at risk for cardiac arrhythmias like bradycardia, tachycardia, and sinus pauses.

The core innovation of the Assert-IQ ICM lies in its AI algorithms, which significantly reduce false positives from Atrial Fibrillation (AF) and Pause episodes while maintaining high sensitivity. These cloud-based neural networks are trained on thousands of electrograms (EGMs) reviewed by electrophysiologists, allowing them to reliably classify episodes in a manner consistent with specialist interpretation. This intelligent filtering of data helps healthcare teams prioritize true AFib episodes, providing clearer insights faster and reducing the burden of managing excessive data. The system also offers remote programmability, enabling clinicians to adjust device settings without requiring in-person patient visits, further streamlining clinic workflow. The Assert-IQ ICM represents a significant advancement in connected health technologies, aiming to improve clinical efficiency and provide actionable data for tailored patient care plans.

Focus Areas

Medical devices (including cardiovascular and neuromodulation products diabetes care products) diagnostics (core lab molecular point of care rapid diagnostics) nutritional products (pediatric and adult nutrition) and established pharmaceuticals (branded generic medicines for sale outside the United States).

Business Intelligence

Key Investors	Vanguard Group Inc, BlackRock, Inc., State Street Corp, Capital Research Global Investors, Geode Capital Management, LLC, Wellington Management Group LLP, UBS Asset Management AG, Norges Bank Investment Management
Partnerships	ALZpath, Samsung, MiniMed, Flatiron Health, Withings, Novo Nordisk, Norton Healthcare Foundation, Barnett International, Real Madrid, Big Ten Conference, WeightWatchers, Freenome
Acquisitions	Exact Sciences (2026), Bigfoot Biomedical (2023), Cardiovascular Systems (2023), Walk Vascular (2021), Cephea Valve Technologies (2019), St. Jude Medical (2016), Alere (2016), Veropharm (2014), Optimedica (2013), Piramal Healthcare Solutions (2010), Facet Biotech (2010), Solvay S.A. pharmaceuticals unit (2010), STARLIMS (2010), Advanced Medical Optics (2009), Kos Pharmaceuticals (2007), TheraSense (2004), Knoll (2001), Ross Laboratories (1964), Pacesetter, Inc. (1994), Daig Corporation (1996), Heart Valve Company (1996), Biocor Industria (1996), Ventritex (1997), Tyco International (Angio-Seal division) (1999), Endocardial Solutions (2005), Advanced Neuromodulation Systems (2005)
Technology	unknown
FDA Clearances	unknown cleared products (estimated)

What Physicians Need to Know

Medical Devices (Assert-IQ ICM)

Abbott's Assert-IQu2122 Insertable Cardiac Monitor (ICM) is a slim, intelligent, and fast device designed for long-term monitoring and diagnostic evaluation of patients experiencing irregular heartbeats. It continuously checks heart rhythms and transmits real-time clinical data. The system features Key Episode technology, allowing clinicians to investigate all episodes or three key episodes, and offers remote programming for physicians to adjust settings and optimize performance. The Assert-IQ ICM also includes supplementary sensors that capture various diagnostics, such as a leading premature ventricular contraction (PVC) detection algorithm and body position and posture. It is the only ICM system to combine AI, the longest-lasting Bluetoothu00ae ICM, and IQ Insights to optimize patient management across arrhythmia types.

AI Agent (General AI Agent concept)

AI agents in healthcare are autonomous software systems that utilize artificial intelligence to perceive information, reason across data, and perform tasks that support clinical care, operations, and patient engagement with minimal human intervention. They are designed to operate with a degree of independence within defined boundaries. These agents can assist with clinical documentation, patient data intake, triage, diagnostics, and care coordination, improving provider efficiency and patient outcomes. AI agents can also power virtual assistants, chatbots, and other tools for appointment scheduling, intake, and basic patient communication.

Diagnostics

Abbott offers a broad range of innovative diagnostic instrument platforms, tests, and services across core lab, molecular, point-of-care, and rapid diagnostics. Their solutions aim to provide accurate, timely information for better health management and to drive operational efficiencies. Abbott is a global leader in rapid diagnostic tests for infectious diseases, cardiometabolic diseases, and toxicology, providing fast, reliable, and actionable information. The Alinity family of solutions is a next-generation line of instruments and informatics designed for greater efficiency and fast, accurate test results.

Nutritional Products

Abbott provides science-based nutritional products for all stages of life, from infancy to adulthood. Their portfolio includes well-known brands such as Similacu00ae infant formulas, Ensureu00ae nutrition shakes, PediaSureu00ae for pediatric nutrition, and Pedialyteu00ae for hydration. They also offer specialized nutrition products like Glucernau00ae for diabetes, Juvenu00ae for wound healing, and Neprou00ae for kidney disease requiring dialysis.

Established Pharmaceuticals

Abbott's Established Pharmaceuticals Division (EPD) focuses on providing high-quality, trusted branded generic medicines for sale outside the United States, particularly in emerging markets. Their strategy involves increasing access to existing products through geographic expansion, improving therapeutic benefits through innovation in formulation and delivery, and expanding local product portfolios. They differentiate themselves through high quality standards, a reliable supply chain, clinical science, and innovation beyond the molecule, such as new delivery methods or digital solutions to improve patient adherence.

Physician Tip

For physicians, Abbott's Assert-IQ ICM offers advanced AI algorithms that significantly reduce false positives for AF and pause events, allowing for more focused review of clinically relevant information. The device's long battery life (up to six years) provides flexibility for long-term monitoring. Remote programming capabilities streamline clinic workflow by allowing adjustments without in-person patient visits. For diagnostics, Abbott's rapid and point-of-care tests provide quick, actionable results to inform timely treatment decisions. The AI Agent concept, when integrated, can automate administrative tasks like clinical documentation, patient data intake, and care coordination, freeing up physician time for patient care. In nutrition, Abbott's science-based products offer a wide range of options to support patients across various life stages and specific disease states. For established pharmaceuticals, the focus on high-quality, affordable branded generics in emerging markets provides trusted treatment options for a broad patient population.

Abbott's Assert-IQ ICM leverages Bluetoothu00ae-enabled technology for automatic and seamless transmission of patient information to the myMerlinu2122 Mobile App and Merlin.netu2122 Patient Care Network portal. The system's AI algorithms work in the cloud, requiring no in-person clinical adjustments to the device. Abbott is also integrating IoT technology into its medical devices for remote monitoring, with a focus on cybersecurity. For their global healthcare SaaS platform for diabetes management, Abbott utilizes full-stack development with technologies like Go, React, Node.js, JavaScript, HTML, CSS, JSX, RESTful APIs, microservices, SQL Server, PostgreSQL, MySQL, Git, Bitbucket, Jira, Confluence, Docker, Kubernetes, Grafana, Segment, Sentry, Mixpanel, and Linux environments. AI agents in healthcare are designed to integrate with enterprise systems and clinical tools, including mobile apps and EHRs, to improve operational efficiency and manage care pathways across multiple teams and systems.

At a glance

Founded 1888

HQ Abbott Park, Illinois, U.S. · United States

Team size Approximately 116,931 (as of March 2026)

CEO Robert B. Ford

Funding Public Company — Unknown

FDA clearances unknown (estimated)

Products 1

Products by Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)

1 product in the directory

Assert-IQ (DM5100)

Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)

Cardiology AI

What the Web Says

Abbott's Assert-IQ ICM is an insertable cardiac monitor that utilizes AI algorithms to improve the accuracy of arrhythmia detection and reduce false positives, aiming to enhance clinical efficiency and patient management. The company Abbott, however, receives mixed reviews as an employer, with some highlighting career growth opportunities and strong technical talent, while others point to a demanding work-life balance, internal politics, and frequent layoffs.

Overall: Mixed

Strengths

Advanced AI algorithms significantly reduce false positives for AF and Pause episodes while maintaining high sensitivity.
Improves clinical efficiency by providing more curated, decision-ready data to healthcare providers, reducing data burden.
Offers extended monitoring with the longest-lasting Bluetoothu00ae ICM, some models with up to six years of battery life.
Provides clear, crisp electrograms (EGMs) for improved visualization of P-waves.
Features remote programmability, allowing clinicians to adjust device settings without in-person patient visits.
Can be a fantastic company for career-focused individuals, offering opportunities for professional growth and a strong network.

Limitations

Abbott's company culture can be perceived as 'toxic' with huge egos and a lot of politics.
Work-life balance can be poor, with tight deadlines and expectations for working across different time zones.
Some employees report feeling undervalued and that resources are tight.
Frequent layoffs are noted as part of Abbott's business model in some divisions.
Customer service for Abbott products has been described as substandard by some customers.
The bureaucracy within Abbott is considered by some to be convoluted and borderline broken.

Based on reviews from: Abbott Cardiovascular (An Inside Look at Assert-IQu2122 ICM, Powered by AI), Abbott Cardiovascular (About Assert-IQ Insertable Cardiac Monitor), Abbott Cardiovascular (An Inside Look at Assert-IQu2122 ICM, Powered by AI - Post-market analysis), Reddit (Opinions on Abbott : r/biotech), Reddit (Abbott work culture : r/biotech), DeepCura Resources (Best AI Agents for Healthcare According to Reddit (2026)), YouTube (Assert-IQ ICM, Now Powered by AI), DAIC (Abbott Receives FDA Clearance for Assert-IQ Insertable Cardiac Monitor), Abbott (Abbott Receives FDA Clearance for Assert-IQu2122 Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term), Medical Product Outsourcing (Abbott's Assert-IQ ICM Earns FDA Nod), Reddit (Has anyone here worked for Abbott? : r/Columbus)

Last updated: 2026-07-28

Videos

News, demos, and interviews about Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept).

Loading videos...

Videos load interactively. If none appear, search YouTube for Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept) →

View all on YouTube

Press & Coverage

Abbott

Abbott Receives FDA Clearance for Assert-IQu2122 Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term

Abbott announced FDA clearance for its Assert-IQu2122 insertable cardiac monitor (ICM), providing physicians with a new option for long-term diagnostic evaluation and monitoring of irregular heartbeats. The device offers battery life options of at least three or six years and remote programming capabilities.

2023-05

Pharmafocus

FDA approves Abbott's Assert-IQ insertable cardiac monitor

The FDA has approved Abbott's Assert-IQ insertable cardiac monitor (ICM), offering doctors a new diagnostic tool for long-term monitoring of irregular heartbeats with battery life options of at least three or six years. The device connects via Bluetooth to a patient's mobile phone, transmitting real-time heart rhythm data to a clinic's portal.

2023-05

Abbott

Abbott Receives CE Mark for its Groundbreaking Assert-IQu2122 Insertable Cardiac Monitor, Expanding Availability of Long-Term Monitoring for Irregular Heart Rhythms

Abbott announced it received CE Mark in Europe for its Assert-IQu2122 insertable cardiac monitor (ICM), providing physicians with a new option for long-term diagnostic evaluation and monitoring of abnormal heartbeats for up to six years. The device utilizes Bluetooth technology to transmit heart rhythm data.

2024-03

Abbott Cardiovascular

An Inside Look at Assert-IQu2122 ICM, Powered by AI

This article discusses the new AI functionality powering Abbott's Assert-IQ ICM system, which uses cloud-based AI algorithms to classify arrhythmia episodes, improve accuracy, and reduce false positives, thereby enhancing clinical efficiency. The AI algorithms are neural networks trained with supervised machine learning.

2026-02

Abbott Newsroom

How do you detect AFib accurately? With the 'eyes' of AI.

Abbott's Assert-IQ insertable cardiac monitor (ICM) system now integrates AI algorithms to accurately detect and classify Atrial Fibrillation (AFib) in near real-time, reducing false positives and providing clearer insights for doctors. The device monitors heartbeats for up to six years.

2026-01

accessdata.fda.gov

Abbott Wing Yan (Winnie) Yik Associate Director, Regulatory Affairs 15900 Valley View Ct Sylmar, California 9

This regulatory filing details the integration of two new artificial intelligence (AI) algorithms into the Assert-IQu2122 ICM remote care component, Merlin.net MN7000, for evaluating atrial fibrillation (AF) and Pause episodes. The AI-enabled function aims to reduce non-actionable clinical review burden due to false positives.

2025-09

PMC

Atrial fibrillation detection performance of an insertable cardiac monitor: Results from an Assert-IQ post-market clinical study and a novel artificial intelligence algorithm

A post-market clinical study found that Assert-IQ ICM accurately detects Atrial Fibrillation (AF) and quantifies its burden for long-term monitoring. The integrated AI algorithm effectively reduces false positives while maintaining high sensitivity, improving the positive predictive value.

2025-11

YouTube (Abbott Cardiovascular)

Assert-IQ ICM, Now Powered by AI

This video highlights that the Assert-IQ ICM is now powered by AI, making it the only ICM system to combine AI with the longest-lasting Bluetooth ICM and IQ Insights for optimized patient management. The AI maintains high patient sensitivity for pause and AF while significantly reducing false positives.

2026-01

Frequently Asked Questions

How does Abbott's Assert-IQ ICM integrate with existing hospital systems and electronic health records (EHRs)?

Abbott's Assert-IQ ICM is designed with interoperability in mind, utilizing standard communication protocols to facilitate seamless integration with various hospital systems and EHR platforms. This allows for efficient data exchange and streamlined workflows for healthcare providers. Specific integration details and capabilities can be discussed with an Abbott representative to ensure compatibility with your institution's infrastructure.

What are the key compliance and regulatory considerations for using Abbott's Assert-IQ ICM and other AI-powered diagnostic tools in a clinical setting?

Abbott's Assert-IQ ICM and other AI-powered diagnostic tools adhere to rigorous regulatory standards set by bodies such as the FDA and EMA. Compliance extends to data privacy (e.g., HIPAA, GDPR), cybersecurity, and the ethical use of AI in healthcare. Abbott provides comprehensive documentation and support to help institutions navigate these compliance requirements and ensure safe and effective implementation.

Can you provide an overview of the pricing structure and available support models for Abbott's medical devices, diagnostics, and nutritional products, particularly for large healthcare networks?

Abbott offers flexible pricing structures and support models tailored to the needs of large healthcare networks, encompassing their medical devices, diagnostics, and nutritional products. These can include volume-based discounts, bundled solutions, and tiered service agreements. Dedicated account managers and technical support teams are available to provide comprehensive assistance, training, and ongoing maintenance.

What kind of partnerships does Abbott pursue to advance its AI capabilities and expand the reach of its healthcare solutions?

Abbott actively pursues strategic partnerships with academic institutions, technology companies, and other healthcare innovators to advance its AI capabilities and broaden the impact of its solutions. These collaborations focus on research and development, co-creation of new technologies, and expanding market access for Abbott's diverse portfolio of medical devices, diagnostics, and nutritional products.

How does Abbott ensure the long-term stability and continuous innovation of its product lines, especially in rapidly evolving areas like AI-driven diagnostics and neuromodulation?

Abbott maintains a strong commitment to research and development, investing significantly in continuous innovation across its product lines, including AI-driven diagnostics and neuromodulation. The company's financial stability, diverse portfolio, and global presence ensure long-term viability and the ability to adapt to evolving healthcare needs and technological advancements. Regular product updates and new releases are part of Abbott's strategy to remain at the forefront of medical innovation.

What training and educational resources does Abbott provide for physicians and staff on the effective use of their diabetes care products and diagnostic platforms?

Abbott offers extensive training and educational resources for physicians and healthcare staff to ensure the effective and safe use of their diabetes care products and diagnostic platforms. This includes on-site training, online modules, webinars, and access to clinical specialists. These resources are designed to optimize product utilization, enhance patient outcomes, and support ongoing professional development.

How does Abbott address data security and patient privacy concerns related to its connected medical devices and diagnostic solutions?

Abbott prioritizes data security and patient privacy across all its connected medical devices and diagnostic solutions. The company employs robust encryption, access controls, and adherence to global data protection regulations like HIPAA and GDPR. Regular security audits and updates are conducted to safeguard sensitive patient information and maintain the highest standards of data integrity.

Related Companies

Suggest an Edit →